De Aller-Bedste Bøger - over 12 mio. danske og engelske bøger
Levering: 1 - 2 hverdage
Hjælp
Login
  1. Forside
  2. Bøger
  3. Business og læring
  4. Risk-sharing in the Pharmaceutical Industry

Risk-sharing in the Pharmaceutical Industry

- The Case of Out-licensing

af Gerrit Reepmeyer

indgår i Contributions to Management Science serien

Risk-sharing in the Pharmaceutical Industry af Gerrit Reepmeyer
Bag om Risk-sharing in the Pharmaceutical Industry

Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously.

Vis mere
  • Sprog:
  • Engelsk
  • ISBN:
  • 9783790816679
  • Indbinding:
  • Paperback
  • Sideantal:
  • 297
  • Udgivet:
  • 5. december 2005
  • Udgave:
  • 2006
  • Størrelse:
  • 234x156x16 mm.
  • Vægt:
  • 970 g.
  • 8-11 hverdage.
  • 2. december 2024

Normalpris

Abonnementspris

- Rabat på køb af fysiske bøger
- 1 valgfrit digitalt ugeblad
- 20 timers lytning og læsning
- Adgang til 70.000+ titler
- Ingen binding

Abonnementet koster 75 kr./md.
Ingen binding og kan opsiges når som helst.

Bag om Gerrit Reepmeyer

Vis alle bøger af Gerrit Reepmeyer

Beskrivelse af Risk-sharing in the Pharmaceutical Industry

Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously.

Brugerbedømmelser af Risk-sharing in the Pharmaceutical Industry



Andre købte også..
Find lignende bøger
Bogen Risk-sharing in the Pharmaceutical Industry findes i følgende kategorier: